Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today

VICTORIA, BC, April 5, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ; , a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology to optimize drug delivery...

Related Keywords

Toronto ,Ontario ,Canada , ,Toronto Stock Exchange ,Nasdaq ,Eupraxia Pharmaceuticals Inc ,Eupraxia Pharmaceuticals ,Nasdaq Capital Market ,Regarding Forward Looking Statements ,Although Eupraxia ,Markets ,